GSA CAPITAL PARTNERS LLP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$65,000
-72.5%
33,571
-57.7%
0.01%
-68.8%
Q1 2022$236,000
+0.4%
79,448
+52.0%
0.03%
+6.7%
Q4 2021$235,000
-39.1%
52,256
-34.2%
0.03%
-23.1%
Q3 2021$386,000
+227.1%
79,436
+360.7%
0.04%
+200.0%
Q2 2021$118,00017,2440.01%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,387,172$6,537,0001.72%
Worth Venture Partners, LLC 969,698$2,366,0001.39%
Omega Fund Management, LLC 1,971,241$3,804,0001.21%
Telemetry Investments, L.L.C. 495,000$955,0001.13%
CM Management, LLC 350,000$676,0000.72%
Bruce & Co., Inc. 1,557,312$3,005,0000.71%
Trellus Management Company, LLC 295,000$569,0000.69%
Abingworth LLP 1,041,131$1,999,0000.64%
1492 Capital Management LLC 489,376$944,0000.62%
GENERAL AMERICAN INVESTORS CO INC 1,752,470$3,382,0000.34%
View complete list of PARATEK PHARMACEUTICALS INC shareholders